Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Cabaletta Bio (CABA)

Cabaletta Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CABA
DateTimeSourceHeadlineSymbolCompany
14/06/202411:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
14/06/202407:00GlobeNewswire Inc.Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201NASDAQ:CABACabaletta Bio Inc
05/06/202400:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
05/06/202400:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
04/06/202421:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
29/05/202413:00GlobeNewswire Inc.Cabaletta Bio to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:CABACabaletta Bio Inc
15/05/202412:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CABACabaletta Bio Inc
15/05/202412:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
15/05/202412:00GlobeNewswire Inc.Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
13/05/202413:00GlobeNewswire Inc.Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:CABACabaletta Bio Inc
21/03/202411:00GlobeNewswire Inc.Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
20/03/202411:00GlobeNewswire Inc.Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic SclerosisNASDAQ:CABACabaletta Bio Inc
04/03/202422:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
04/03/202422:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
04/03/202422:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
04/03/202422:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
04/03/202422:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
27/02/202413:00GlobeNewswire Inc.Cabaletta Bio to Participate in Upcoming Investor Conferences in MarchNASDAQ:CABACabaletta Bio Inc
14/02/202414:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CABACabaletta Bio Inc
13/02/202423:47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CABACabaletta Bio Inc
01/02/202421:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
01/02/202421:30GlobeNewswire Inc.Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of MyositisNASDAQ:CABACabaletta Bio Inc
31/01/202413:00GlobeNewswire Inc.Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:CABACabaletta Bio Inc
19/01/202423:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
08/01/202412:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
08/01/202412:00GlobeNewswire Inc.Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic SclerosisNASDAQ:CABACabaletta Bio Inc
02/01/202413:00GlobeNewswire Inc.Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CABACabaletta Bio Inc
20/12/202301:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
29/11/202311:18IH Market NewsAmazon Unveils Innovative Services, Okta Discloses Data Breach, Textron Plans 2% Global Workforce Reduction, and MoreNASDAQ:CABACabaletta Bio Inc
28/11/202321:30GlobeNewswire Inc.Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:CABACabaletta Bio Inc
 Showing the most relevant articles for your search:NASDAQ:CABA